quinazolines has been researched along with Atheroma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Z; Han, J; Lin, J; Lin, Y; Peng, W; Qin, Y; Shi, X; Xiao, F; Xu, X; Zhang, Y; Zhao, L | 1 |
| Banach, M; Mikhailidis, DP; Nikolic, D; Rizzo, M; Wong, NC | 1 |
| Ballantyne, CM; Barter, PJ; Borgman, M; Brewer, HB; Herrman, JP; Hu, B; Kastelein, JJ; Kataoka, Y; Merkely, B; Nicholls, SJ; Nissen, SE; Puri, R; Uno, K; Wolski, K | 1 |
| Badimon, JJ; Bauriedel, G; Huber, K; Hutter, R; Kastl, SP; Katsaros, KM; Kaun, C; Maurer, G; Speidl, WS; Wojta, J | 1 |
| Ballantyne, CM; Barter, PJ; Borgman, MR; Brewer, HB; Gordon, A; Johannson, J; Kastelein, JJ; Nicholls, SJ; Nissen, SE; Wong, NC | 1 |
1 review(s) available for quinazolines and Atheroma
| Article | Year |
|---|---|
An evaluation of RVX-208 for the treatment of atherosclerosis.
Topics: Animals; Atherosclerosis; Cholesterol, HDL; Epigenesis, Genetic; Humans; Metabolic Diseases; Plaque, Atherosclerotic; Quinazolines; Quinazolinones | 2015 |
2 trial(s) available for quinazolines and Atheroma
| Article | Year |
|---|---|
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial.
Topics: Aged; Apolipoprotein A-I; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Prospective Studies; Quinazolines; Quinazolinones | 2016 |
ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies.
Topics: Adolescent; Apolipoprotein A-I; Cardiotonic Agents; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Female; Follow-Up Studies; Humans; Male; Plaque, Atherosclerotic; Quinazolines; Quinazolinones; Ultrasonography | 2012 |
2 other study(ies) available for quinazolines and Atheroma
| Article | Year |
|---|---|
Tryptanthrin Regulates Vascular Smooth Muscle Cell Phenotypic Switching in Atherosclerosis by AMP-Activated Protein Kinase/Acetyl-CoA Carboxylase Signaling Pathway.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Atherosclerosis; Becaplermin; Cell Plasticity; Cells, Cultured; Disease Models, Animal; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Phenotype; Phosphorylation; Plaque, Atherosclerotic; Quinazolines; Signal Transduction | 2021 |
The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro.
Topics: Cells, Cultured; Complement C5a; Coronary Vessels; Fluorescent Antibody Technique; Gene Expression; Humans; Immunohistochemistry; Macrophages; Masoprocol; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; NF-kappa B; Plaque, Atherosclerotic; Quinazolines; Receptor, Anaphylatoxin C5a; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factor AP-1 | 2011 |